Publicerad: 2020-12-16 09:08 | Uppdaterad: 2020-12-16 09:12

Aktuella utlysningar, vecka 51, 2020

Grants Office tipsar om aktuella utlysningar.

Svenska och nordiska utlysningar

Call for proposals – COVID-19 pandemic research and preparedness

SciLifeLab, with support from Knut and Alice Wallenberg Foundation, now seeks proposals within five calls on COVID-19 research:

1. Proposals from existing research areas (RAs) in the SciLifeLab-KAW COVID-19 program
2. Proposals from individual scientists with new contributions to the SciLifeLab-KAW COVID-19 research program
3. New KAW supported COVID-19 research program on vaccine effects
4. Laboratory preparedness for pandemics
5. Data-driven life science (DDLS) on COVID-19

Closing  date: for Call 1-3 and Call 5 – January 15, 2021. For Call 4, January 31, 2021.

Further information

Anslag för Forskningsmånader – Radiumhemmets Forskningsfonder

Radiumhemmets Forskningsfonder har beslutat utlysa ett antal forskningsmånader för doktorander vid Karolinska Institutet som är kliniskt verksamma inom cancerområdet i Region Stockholm.

Closing date: 24 January 2021

Further information

Fellow grants for postdoctoral education – Wenner-Gren Foundation

These enable young researchers to obtain qualified postdoctoral training abroad for up to three years and thereafter to conduct research activities in Sweden for two years.

Closing date: 31 January 2021

Further information

Innovation projects – Medtech4Health

These aim to develop and adopt artificial intelligence-based decision support methods for imaging diagnostics. Grants may cover up to 50 percent of costs for project proposals of between SEK 500,000 and SEK 1 million.

Closing date: 31 January 2021

Further information

Applied welfare research – Swedish Research Council for Health, Working Life and Welfare (Forte)

Forte’s national programme on applied welfare research aims to strengthen long-term knowledge expansion and development within the field of applied social services, and to strengthen collaboration between research and practice.

  • Project grants: Funding for individual research projects. Grants are worth up to approximately SEK 1.3 million per year for three to four years.
  • Programme grant: Programme grants aim to strengthen applied welfare research on a long-term basis and enable the development of research environments.  Grants are worth up to approximately SEK 4 million per year for up to six years.
  • International Postdoc: This enables new doctoral researchers to continue their research career with a focus on the social services field of activity. There are incoming and outgoing grants. Grants are worth up to SEK 2.35 million over two years.

Closing date: 9 February 2021

Further information

Forskningsmedel - Försäkringskassan

Försäkringskassan utlyser forskningsmedel för projekt om socialförsäkringen och Försäkringskassans verksamhet. Syftet är att utveckla kunskapen om socialförsäkringen och dess funktion för individ och samhälle samt att stödja implementering av forskningsbaserade insatser inom socialförsäkringsområdet.

Closing date: 28 February 2021

Further information

Stiftelsen Sunnerdahls Handikappfond

Stiftelsen Sunnerdahls Handikappfond stödjer forskning samt utvecklingsarbete kring barn och ungdomar med funktionsnedsättning. Fokus ligger på faktorer som påverkar deras hälsa, lärande och livssituation. Anslag delas i huvudsak ut till samhällsvetenskaplig, pedagogisk och medicinsk forskning, samt i vissa fall till utvecklingsarbete av generaliserbar karaktär. Vid bedömningen av ansökningar prioriteras forskning som syftar till att förbättra livssituationen för barn och ungdomar med funktionsnedsättning. Tillämpad forskning som förbättrar situationen för målgrupperna välkomnas särskilt, samt projekt där barn och ungdomar själva är delaktiga. Forskning på hög vetenskaplig nivå som är nyskapande och gäller för hela målgrupper prioriteras.

Closing date: April 30, 2021

Further information

Europeiska utlysningar

Catalyst grants - Breast Cancer Now

Breast Cancer Now, in collaboration with Pfizer, invites expressions of interest for its catalyst grants. These support research projects that address problems in breast cancer and involve the use of drugs available from Pfizer. Proposals may include:

  • early phase clinical studies – phase I/II;
  • clinical studies of the drugs in combination with other drugs, including those from other companies, or other treatment modalities;
  • pre-clinical research investigating the mechanisms of action of the drugs;
  • pre-clinical research that could lead to repurposing existing drugs, including new indications for already licensed drugs;
  • research to develop and test biomarkers or diagnostics to be used with the drugs.

PIs based in an academic institution, such as a university, hospital or research institute within Europe may apply. International collaborations are eligible. Applicants must undertake research using at least one of the Pfizer drugs. The size of each grant will vary according to the nature and scope of the proposed research. Grants of up to £400,000 in total are likely to address a single research question. Large grants of up to £1.5 million in total are for larger studies of exceptional potential.

Closing date: 5 February 2021

Further information

Pezcoller/Marina Larcher Fogazzaro/EACR women in cancer research award - European Association for Cancer Research

The European Association for Cancer Research invites nominations for the Pezcoller/Marina Larcher Fogazzaro/EACR women in cancer research award. This recognises achievements by women in the field of cancer research. Self-nominations are not allowed. Nominees must have spent the majority of their research career in Europe and be employed by a research institute in Europe.

The award is worth €10,000. The winner also gives the Pezcoller-Marina Larcher Fogazzaro-EACR women in cancer research award lecture at the EACR congress.

Closing date: 11 January 2021

Further information

Research grants - European Society of Cardiology

The European Society of Cardiology invites applications for its research grants. These enable members to undertake specialised cardiovascular research or further training in the field in an ESC regular member country. Applicants must be below 40 years of age and be citizens or permanent residents of an ESC member or affiliated member country throughout the three years preceding the application date. They must hold a PhD or DPhil degree or equivalent, or must have submitted a thesis before taking up the fellowship. Medical graduates may apply if they have completed their basic professional training and are able to demonstrate their expertise through abstract presentation at a national or international meeting, or have published a paper in a relevant journal. Applicants must be members of the ESC. Applicants are allowed to apply to an institution based in their own country, provided it is not their home institution. Grants are worth €25,000 each per year for projects lasting between three months and one year.

Closing date: 31 January 2021

Further information

Eurostars programme - EUREKA, EU and other funders

EUREKA invites applications for the Eurostars programme. This supports international R&D projects that create innovative products, processes or services for commercialisation. The programme enables companies to turn an idea into a product and commercialise it, combine and share expertise and benefit from working across national borders.

Any type of organisation can be part of a Eurostars project consortium, but the consortium leader must be an R&D-performing SME from a Eurostars country. Consortia must include at least two participants from two different Eurostars countries. Projects may last for up to three years. Funding may vary depending on national rules and regulations.

Closing date: 4 February 2021

Further information

Amerikanska utlysningar

Federal Funding agencies

Notice of Special Interest (NOSI): Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities

The National Institute on Minority Health and Health Disparities intends to promote a new initiative by publishing a Notice of Special Interest to solicit applications for research highlighting the important need for community-engaged research to address vaccine hesitancy, uptake, and implementation among populations who experience health disparities.

This Notice is being provided to allow potential applicants additional time to develop responsive applications.

The FOA is expected to be published in December 2020 and we will accept applications in February 2021 for FY21 funding. The FOA will be a Notice of Special Interest (NOSI) for R01 projects. The goal is to make awards by September 2021.

First available due date: February 05, 2021.

Closing date: TBD

Related Funding Opportunity Announcement (FOA): PA-20-183 - Research Project Grant (Parent R01 Clinical Trial Required), PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed

Further information 

Notice of Special Interest: Tailoring Follow-up Care for Survivors Using Risk-Stratified Pathways

The purpose of this Notice is to highlight the NCI Division of Cancer Control and Population Sciences’ interest in receiving applications focused on identifying important factors for defining risk-stratified survivorship care or developing and testing approaches to improve the clinical management and outcomes for adult cancer survivors using risk-stratified survivorship care pathways.

Risk-stratified survivorship care describes a personalized approach to care in which cancer survivors are triaged or stratified to distinct care pathways based on the complexity of their needs and the types of providers their care requires.

First available due date: February 05, 2021.

Closing date: February 05, 2023

Related Funding Opportunity Announcement (FOA): PAR-21-035 - Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required); PAR-18-869 - Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional); PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed); PAR-19-274 - Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Further information 

Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed), NIH

This Funding Opportunity Announcement (FOA), issued by the National Institute on Aging (NIA) of the National Institutes of Health, solicits grant applications that will examine the role of aging in the interactions between the immune systems and skeletal systems in animal models. Research projects that will determine the mechanisms involved in how both aging of the bone marrow niche and immunosenescence impact these interactions, leading to pathological conditions in bone homeostasis, are the focus of this FOA.

Closing date: Standard dates apply. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-AG-22-002.

Further information 

Mood Disorders in People Living with HIV: Mechanisms and Pathways (R01, R21 Clinical Trial Optional), NIH

The purpose of this Funding Opportunity Announcement (FOA) is to support studies to better understand the underlying mechanisms and interplay of biological, psychosocial and structural factors contributing to mood disorders in people living with HIV. Applications testing a fully conceptualized and hypothesis-based solid premise founded with adequate preliminary data are appropriate for this FOA. Exploratory and high-risk research projects should consider applying to the companion R21 announcement RFA-MH-21-117. Basic and preclinical research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Closing date: March 10, 2021. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-MH-21-116 (R01); RFA-MH-21-117 (R21).

Further information (R01)

Further information (R21)

New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed), NIH

The purpose of the ASPIRE Collaborative Research Program is to facilitate translational and clinical research between NCATS intramural scientists and the extramural community to develop approaches that will enhance the ability to discover and develop new chemistries towards previously undrugged biological targets (i.e., biological targets with no known drugs to modulate their function) across many human diseases and conditions. NCATS intramural scientists have established an integrated NCATS ASPIRE platform consisting of physical and virtual modules for automated synthetic chemistry, artificial intelligence (AI) and machine learning (ML), engineering, informatics, and biological testing. The FOA will support intramural - extramural collaborations to develop additional physical modules that will enhance the platform’s capabilities. The anticipated outcome includes identification, design, synthesis, and validation of new chemical entities as starting points for drug development of novel targets, and the expansion of chemical space available for drug screening.

Closing date: July 8, 2021. No late applications will be accepted for this Funding Opportunity Announcement.

Funding Opportunity Announcement (FOA): RFA-TR-21-001 (R01).

Further information 

McGill’s 2021 Louis and Artur Lucian Award for Research in Circulatory Diseases

The Award is designed to honour outstanding research in the field of circulatory diseases by a scientific investigator or group of investigators whose contribution to knowledge in this field is deemed worthy of special recognition. As per the terms of the bequest, the work of the nominee must be current. The Louis and Artur Lucian Award consists of a $70,000 CDN prize to the recipient. It is hoped that through this Award, collaborative research in the field of circulatory diseases can be established between McGill and research centres elsewhere in Canada, the United States and other countries of the world.

Closing date: April 2, 2021

Further information


Research Award, Massage Therapy Foundation (MTF), US

Massage Therapy Foundation research grants are awarded to individuals or teams conducting studies that promise to advance our understanding of specific therapeutic applications of massage, public perceptions of and attitudes toward massage therapy, and the role of massage therapy in health care delivery.

MTF research grants support high quality, independent research that contributes to the basic science of massage therapy application, including applied research investigating massage therapy as a health/mental health treatment and/or prevention modality. The research grant is available to investigators who have experience in the relevant field of research, and are presently associated with a university, independent research organization, or other institution qualified to act as Sponsoring Organization.

MTF Research Award (over $30,000)

  • Amount awarded is between $30,000 to $300,000 and must be used in the specific time period for which it has been awarded (can be used over the course of multiple years).

Closing date: Research Award pre-proposal (LOI) submission deadline: March 1, 2021 at 5:00 pm EST

Research Award full proposal submission deadline: June 1, 2021 at 5:00 pm EST

Further information 

General Research Grants, Friedreich's Ataxia Research Alliance (FARA), US

Friedreich's Ataxia Research Alliance invites letters of intent for its general research grants. These support research on Friedreich’s ataxia. Research must fall within one of the following areas:

•advancing understanding of neuroscience systems;

•advancing understanding of cardiac disease in FA;

•advancing understanding of the molecular basis of FA;

•advancing drug discovery;

•facilitating the drug development process and translational research;

•advancing clinical research.

Qualified investigators may apply for projects that target FARA’s research priorities.

Grants are worth up to USD 150,000 per year for one or two years

Closing date: February 1, 2021 (LOI); April 1, 2021 (Full proposal).

Further information   

Research Grants, Sarcoma Foundation of America (SFA), US

The Sarcoma Foundation of America (SFA) is pleased to announce a research funding opportunity to provide one-year grants in the amount of $50,000, to support translational science research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas.

The SFA encourages applications that focus on the following areas of research for the 2021 cycle:

  • Immunotherapy
  • Omic characterization of sarcomas and definition of novel targets
  • Omic patterns of sensitivity and resistance to existing agents
  • Systemic therapy combinations
  • Gene Therapy

Closing date: February 1, 2021 at 5pm ET (Full Proposal).

Further information